- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Segment 2 - Bringing Latest Innovations to the Public
Jianda Yuan, MD, PhD, explains the importance of bringing the latest innovations to the public and how more data are showing promising immunologic and clinical responses for different types of cancer.
Jianda Yuan, MD, PhD, explains the importance of bringing the latest innovations to the public and how more data are showing promising immunologic and clinical responses for different types of cancer.
Medical conferences are presenting premium data from more phase I and II studies and not only are organizations picking up on the studies of PD-1 and PD-L1, but so is the mainstream media, which brings the data to different levels of society.
Kimberly Shafer-Weaver, PhD, added that there needs to be more education of physicians regarding how immunotherapy can be added into the regime for a patient.
“And it is amazing that, you know, right now, standard of care is not immunotherapy, but we are really finding that quickly if it is something that should be added and with standard of care early on when the patient has a good ability to respond because an immune system is intact,” Dr Shafer-Weaver said.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
